Britain-based GlaxoSmithKline Plc has agreed to buy Maxinutrition Group Holdings Ltd, a UK-based manufacturer of protein-enhanced nutritional products, for $255 million in cash. Glaxo will purchase all of the shares of Maxinutrition from London-based Darwin Private Equity...